Exelixis (EXEL) Return on Capital Employed [ROCE] (2011 - 2026)
Exelixis (EXEL) posted Return on Capital Employed [ROCE] of 44.52% for Q2 2027, up 15.63 percentage points from 28.90% a year earlier and up 4.63 percentage points from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2026, Exelixis' Return on Capital Employed [ROCE] came in at 35.02%, up 11.23 percentage points from FY2025.
- Annual Return on Capital Employed [ROCE] shows a five-year change of +20.96 percentage points (FY2021 to FY2026).
- In prior years, Exelixis' Return on Capital Employed [ROCE] was 23.79% in FY2025, 6.54% in FY2023 (-1.46 pp) and 8.00% in FY2022 (-6.06 pp).
- The Q2 2027 figure stands as the highest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2020.
- On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last six quarters, with an average year-over-year change of +14.52 percentage points over the last six quarters.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was 39.89% (Q1 2027), 35.92% (Q4 2026) and 33.66% (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Exelixis | 14.53 Bn | 10.87 Bn | 608.03 Mn | 44.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 44.52% |
| Apr 3, 2026 | 39.89% |
| Jan 2, 2026 | 35.92% |
| Oct 3, 2025 | 33.66% |
| Jul 4, 2025 | 28.90% |
| Apr 4, 2025 | 30.56% |
| Jan 3, 2025 | 23.71% |
| Sep 27, 2024 | 21.16% |
| Jun 28, 2024 | 15.13% |
| Mar 29, 2024 | 6.86% |
| Dec 29, 2023 | 6.66% |
| Sep 29, 2023 | 1.53% |
| Jun 30, 2023 | 5.04% |
| Mar 31, 2023 | 5.29% |
| Dec 30, 2022 | 7.48% |
| Sep 30, 2022 | 14.03% |
| Jul 1, 2022 | 13.66% |
| Apr 1, 2022 | 16.02% |
| Dec 31, 2021 | 13.13% |
| Oct 1, 2021 | 9.09% |
API Access
Exelixis Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();